• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉钙化积分与日本血液透析患者的死亡率相关。

Coronary artery calcification score is associated with mortality in Japanese hemodialysis patients.

机构信息

Department of Advanced Medicine for Uremia, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Japan.

出版信息

J Ren Nutr. 2012 Jan;22(1):139-42. doi: 10.1053/j.jrn.2011.10.024.

DOI:10.1053/j.jrn.2011.10.024
PMID:22200431
Abstract

OBJECTIVE

Coronary artery calcification has been associated with higher mortality in coronary artery disease and chronic kidney disease. This study aimed to correlate coronary artery calcification score (CACS) with all-cause and cardiovascular mortalities in hemodialysis (HD) patients.

DESIGN, SETTING, SUBJECTS: A survival analysis was conducted in 200 HD patients. CACS was assessed by multidetector-row computed tomography and stratified as tertiles: group 1 (0∼105 U), group 2 (110∼1067 U), and group 3 (1094∼15481 U). The duration of follow-up was 7 years and 4 months. Kaplan-Meier method and Cox proportional hazard analysis adjusted for age and HD duration were performed to examine the impact of CACS on survival.

MAIN OUTCOME MEASURE

All-cause and cardiovascular mortalities were measured.

RESULTS

The cumulative all-cause and cardiovascular mortalities of group 1 were significantly lower than those of groups 2 and 3 (all-cause mortality: 7.6% vs. 43.3% and 52.2%, respectively, cardiovascular mortality: 3.0% vs. 22.4% and 26.9%, respectively). Cox proportional hazard analysis adjusted for age and HD duration revealed that all-cause and cardiovascular mortalities of group 1 were significantly lower than those of groups 2 and 3.

CONCLUSION

CACS is helpful to predict prognosis of HD patients independently of age and HD duration.

摘要

目的

冠状动脉钙化与冠心病和慢性肾脏病的死亡率升高有关。本研究旨在探讨冠状动脉钙化评分(CACS)与血液透析(HD)患者全因和心血管死亡率的相关性。

设计、地点、研究对象:对 200 名 HD 患者进行生存分析。采用多排螺旋 CT 评估 CACS,并分为三分位:第 1 组(0∼105 U)、第 2 组(110∼1067 U)和第 3 组(1094∼15481 U)。随访时间为 7 年 4 个月。采用 Kaplan-Meier 法和 Cox 比例风险分析,调整年龄和 HD 持续时间,观察 CACS 对生存率的影响。

主要观察指标

全因和心血管死亡率。

结果

第 1 组的累积全因和心血管死亡率明显低于第 2 组和第 3 组(全因死亡率:7.6%比 43.3%和 52.2%,心血管死亡率:3.0%比 22.4%和 26.9%)。经年龄和 HD 持续时间校正的 Cox 比例风险分析显示,第 1 组的全因和心血管死亡率明显低于第 2 组和第 3 组。

结论

CACS 有助于独立于年龄和 HD 持续时间预测 HD 患者的预后。

相似文献

1
Coronary artery calcification score is associated with mortality in Japanese hemodialysis patients.冠状动脉钙化积分与日本血液透析患者的死亡率相关。
J Ren Nutr. 2012 Jan;22(1):139-42. doi: 10.1053/j.jrn.2011.10.024.
2
Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis.高冠状动脉钙化评分(CACS)对慢性血液透析患者生存的影响。
Clin Exp Nephrol. 2004 Mar;8(1):54-8. doi: 10.1007/s10157-003-0260-0.
3
Coronary Artery Calcification Score as A Predictor of All-Cause Mortality and Cardiovascular Outcome in Peritoneal Dialysis Patients.冠状动脉钙化评分作为腹膜透析患者全因死亡率和心血管结局的预测指标
Perit Dial Int. 2016 Mar-Apr;36(2):163-70. doi: 10.3747/pdi.2014.00124. Epub 2015 Jul 29.
4
The relationship between coronary artery calcium scores and left atrium size in hemodialysis patients.血液透析患者冠状动脉钙化积分与左心房大小的关系。
Int Urol Nephrol. 2017 Sep;49(9):1661-1666. doi: 10.1007/s11255-017-1620-0. Epub 2017 May 18.
5
Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients.维持性血液透析患者血清胎球蛋白 A 水平、冠状动脉钙化与骨密度的相关性。
Artif Organs. 2009 Oct;33(10):844-54. doi: 10.1111/j.1525-1594.2009.00814.x. Epub 2009 Jul 22.
6
Impact of coronary artery calcification in hemodialysis patients: Risk factors and associations with prognosis.冠状动脉钙化对血液透析患者的影响:危险因素及与预后的关联。
Hemodial Int. 2010 Apr;14(2):218-25. doi: 10.1111/j.1542-4758.2009.00423.x. Epub 2010 Mar 24.
7
Vascular calcification estimated by aortic calcification area index is a significant predictive parameter of cardiovascular mortality in hemodialysis patients.血管钙化程度通过主动脉钙化面积指数评估,是血液透析患者心血管死亡率的重要预测指标。
Clin Exp Nephrol. 2011 Dec;15(6):877-83. doi: 10.1007/s10157-011-0517-y. Epub 2011 Aug 19.
8
Iron, coronary artery calcification, and mortality in patients undergoing hemodialysis.血液透析患者的铁、冠状动脉钙化和死亡率。
Ren Fail. 2021 Dec;43(1):371-380. doi: 10.1080/0886022X.2021.1880937.
9
Cardiovascular risk assessment and coronary artery calcification burden in asymptomatic patients in the initial years of hemodialysis.在开始血液透析的最初几年,对无症状患者进行心血管风险评估和冠状动脉钙化负担评估。
Ther Apher Dial. 2022 Feb;26(1):64-70. doi: 10.1111/1744-9987.13641. Epub 2021 Mar 31.
10
Coronary calcification and its association with mortality in haemodialysis patients.血液透析患者的冠状动脉钙化及其与死亡率的关联。
Nephrology (Carlton). 2009 Apr;14(2):164-70. doi: 10.1111/j.1440-1797.2008.01020.x.

引用本文的文献

1
Relationship between the triglyceride-glucose index and coronary artery calcification in asymptomatic, non-diabetic patients undergoing maintenance hemodialysis.在接受维持性血液透析的无症状、非糖尿病患者中,甘油三酯-葡萄糖指数与冠状动脉钙化的关系。
Ren Fail. 2023 Dec;45(1):2200849. doi: 10.1080/0886022X.2023.2200849.
2
Impact of Arterial Calcification of the Lower Limbs on Long-Term Clinical Outcomes in Patients on Hemodialysis.下肢动脉钙化对血液透析患者长期临床结局的影响
J Clin Med. 2023 Feb 6;12(4):1299. doi: 10.3390/jcm12041299.
3
Cholecalciferol supplementation effectively improved tertiary hyperparathyroidism, FGF23 resistance and lowered coronary calcification score: a prospective study.
补充胆钙化醇有效改善了三发性甲状旁腺功能亢进、成纤维细胞生长因子23抵抗并降低了冠状动脉钙化评分:一项前瞻性研究。
Endocr Connect. 2022 Jul 25;11(8). doi: 10.1530/EC-22-0123. Print 2022 Aug 1.
4
Multimodality Tachycardia-Induced Stress Testing Predicts a Low-Risk Group for Early Cardiovascular Mortality After Renal Transplantation.多模态心动过速诱发应激试验可预测肾移植术后早期心血管死亡的低风险组。
Kidney Int Rep. 2020 Oct 22;6(1):120-127. doi: 10.1016/j.ekir.2020.10.006. eCollection 2021 Jan.
5
Coronary calcification as a predictor of cardiovascular mortality in advanced chronic kidney disease: a prospective long-term follow-up study.冠状动脉钙化作为晚期慢性肾脏病心血管死亡的预测指标:一项前瞻性长期随访研究
BMC Nephrol. 2019 May 28;20(1):188. doi: 10.1186/s12882-019-1367-1.
6
Hyperphosphatemia and hs-CRP Initiate the Coronary Artery Calcification in Peritoneal Dialysis Patients.高磷血症和超敏C反应蛋白引发腹膜透析患者的冠状动脉钙化。
Biomed Res Int. 2017;2017:2520510. doi: 10.1155/2017/2520510. Epub 2017 Feb 22.
7
Coronary Artery Calcification Seen Through Chest Radiography.通过胸部X线摄影观察到的冠状动脉钙化
J Clin Med Res. 2015 Sep;7(9):724-5. doi: 10.14740/jocmr2121w. Epub 2015 Jul 24.
8
Coronary Artery Calcification Score as A Predictor of All-Cause Mortality and Cardiovascular Outcome in Peritoneal Dialysis Patients.冠状动脉钙化评分作为腹膜透析患者全因死亡率和心血管结局的预测指标
Perit Dial Int. 2016 Mar-Apr;36(2):163-70. doi: 10.3747/pdi.2014.00124. Epub 2015 Jul 29.
9
Hyperphosphatemia as an independent risk factor for coronary artery calcification progression in peritoneal dialysis patients.高磷血症作为腹膜透析患者冠状动脉钙化进展的独立危险因素。
BMC Nephrol. 2015 Jul 18;16:107. doi: 10.1186/s12882-015-0103-8.
10
Coronary artery disease in patients with chronic kidney disease: a clinical update.慢性肾脏病患者的冠状动脉疾病:临床最新进展
Curr Cardiol Rev. 2013 Nov;9(4):331-9. doi: 10.2174/1573403x10666140214122234.